NCT06581432 2026-04-17
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Boehringer Ingelheim
Phase 2 Recruiting
Boehringer Ingelheim
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Institut Claudius Regaud
Orion Corporation, Orion Pharma
AP Biosciences Inc.
Race Oncology Ltd